The Worldwide CAR T-cell therapy market is undergoing a period of exponential growth. This increase can be attributed to several factors, including the rising prevalence of hematological malignancies, progresses in cell therapy, and supportive regulatory recognitions. The market is segmented by type of CAR T-cell therapy, indication, level of thera